Given the heterogeneity of cancer-associated fibroblasts (CAFs), in addition to α-SMA+ myofibroblasts (myCAFs), we also examined the effect of PGRN on another important CAF subtype, the inflammatory CAFs (iCAFs). The gene discussed is GRN; the disease is cancer.